Trial Profile
A double blind, randomized, parallel group study of palonosetron in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Oct 2016
Price :
$35
*
At a glance
- Drugs Palonosetron (Primary) ; Moxifloxacin
- Indications Nausea and vomiting
- Focus Adverse reactions
- Sponsors Helsinn Healthcare SA; MGI Pharma
- 05 Mar 2008 New trial record.